'Alport-like (syndrome)'
(id=16860995 ; fe=Alport-like (syndrome) ; type=1 ; niveau=200 ;
luminosité=25 ;
somme entrante=1558 creation date=2021-07-25 touchdate=2025-08-31 22:41:14.000) ≈ 24 relations sortantes
- Alport-like (syndrome) --
r_isa #6: 36 / 1 ->
syndrome
n1=Alport-like (syndrome) | n2=syndrome | rel=r_isa | relid=6 | w=36
- Alport-like (syndrome) --
r_isa #6: 30 / 0.833 ->
processus pathologique
n1=Alport-like (syndrome) | n2=processus pathologique | rel=r_isa | relid=6 | w=30
- Alport-like (syndrome) --
r_isa #6: 15 / 0.417 ->
analyte
n1=Alport-like (syndrome) | n2=analyte | rel=r_isa | relid=6 | w=15
- Alport-like (syndrome) --
r_isa #6: 15 / 0.417 ->
anticonvulsant
n1=Alport-like (syndrome) | n2=anticonvulsant | rel=r_isa | relid=6 | w=15
- Alport-like (syndrome) --
r_isa #6: 15 / 0.417 ->
anxiolytique
n1=Alport-like (syndrome) | n2=anxiolytique | rel=r_isa | relid=6 | w=15
- Alport-like (syndrome) --
r_isa #6: 15 / 0.417 ->
benzodiazépine
n1=Alport-like (syndrome) | n2=benzodiazépine | rel=r_isa | relid=6 | w=15
- Alport-like (syndrome) --
r_isa #6: 15 / 0.417 ->
benzodiazépine à courte durée d'action
n1=Alport-like (syndrome) | n2=benzodiazépine à courte durée d'action | rel=r_isa | relid=6 | w=15
- Alport-like (syndrome) --
r_isa #6: 15 / 0.417 ->
composé chimique
n1=Alport-like (syndrome) | n2=composé chimique | rel=r_isa | relid=6 | w=15
- Alport-like (syndrome) --
r_isa #6: 15 / 0.417 ->
en:analyte
n1=Alport-like (syndrome) | n2=en:analyte | rel=r_isa | relid=6 | w=15
- Alport-like (syndrome) --
r_isa #6: 15 / 0.417 ->
en:anticonvulsant
n1=Alport-like (syndrome) | n2=en:anticonvulsant | rel=r_isa | relid=6 | w=15
- Alport-like (syndrome) --
r_isa #6: 15 / 0.417 ->
en:chemical compound
n1=Alport-like (syndrome) | n2=en:chemical compound | rel=r_isa | relid=6 | w=15
- Alport-like (syndrome) --
r_isa #6: 15 / 0.417 ->
en:medicament
n1=Alport-like (syndrome) | n2=en:medicament | rel=r_isa | relid=6 | w=15
- Alport-like (syndrome) --
r_isa #6: 15 / 0.417 ->
en:medicine
n1=Alport-like (syndrome) | n2=en:medicine | rel=r_isa | relid=6 | w=15
- Alport-like (syndrome) --
r_isa #6: 15 / 0.417 ->
en:tablet
n1=Alport-like (syndrome) | n2=en:tablet | rel=r_isa | relid=6 | w=15
- Alport-like (syndrome) --
r_isa #6: 15 / 0.417 ->
hypnotique
n1=Alport-like (syndrome) | n2=hypnotique | rel=r_isa | relid=6 | w=15
- Alport-like (syndrome) --
r_isa #6: 15 / 0.417 ->
matière
(substance)
n1=Alport-like (syndrome) | n2=matière (substance) | rel=r_isa | relid=6 | w=15
- Alport-like (syndrome) --
r_isa #6: 15 / 0.417 ->
médicament
n1=Alport-like (syndrome) | n2=médicament | rel=r_isa | relid=6 | w=15
- Alport-like (syndrome) --
r_isa #6: 15 / 0.417 ->
medicament
n1=Alport-like (syndrome) | n2=medicament | rel=r_isa | relid=6 | w=15
- Alport-like (syndrome) --
r_isa #6: 15 / 0.417 ->
médicament sur ordonnance
n1=Alport-like (syndrome) | n2=médicament sur ordonnance | rel=r_isa | relid=6 | w=15
- Alport-like (syndrome) --
r_isa #6: 15 / 0.417 ->
psychotrope
n1=Alport-like (syndrome) | n2=psychotrope | rel=r_isa | relid=6 | w=15
- Alport-like (syndrome) --
r_isa #6: 15 / 0.417 ->
sédatif
n1=Alport-like (syndrome) | n2=sédatif | rel=r_isa | relid=6 | w=15
- Alport-like (syndrome) --
r_isa #6: 15 / 0.417 ->
substance
n1=Alport-like (syndrome) | n2=substance | rel=r_isa | relid=6 | w=15
- Alport-like (syndrome) --
r_isa #6: 15 / 0.417 ->
substance à analyser
n1=Alport-like (syndrome) | n2=substance à analyser | rel=r_isa | relid=6 | w=15
- Alport-like (syndrome) --
r_isa #6: 15 / 0.417 ->
substance
(matière)
n1=Alport-like (syndrome) | n2=substance (matière) | rel=r_isa | relid=6 | w=15
| ≈ 0 relations entrantes
|